MARK1 anticorps (C-Term) (PE)
MARK1
Reactivité: Humain
WB, ELISA, IHC, FACS
Hôte: Lapin
Polyclonal
PE
N° du produit ABIN2307863
-
-
Antigène
Voir toutes MARK1 Anticorps
-
MARK1
(MAP/microtubule Affinity-Regulating Kinase 1 (MARK1))
-
Épitope
-
C-Term
-
Reactivité
-
Humain
-
Hôte
-
Lapin
-
Clonalité
-
Polyclonal
-
Conjugué
-
Cet anticorp MARK1 est conjugé à/à la PE
-
Application
-
Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Flow Cytometry (FACS)
-
Réactivité croisée
-
Humain
-
Réactivité croisée (Details)
-
Calculated cross reactivity: Hu
-
Attributs du produit
-
MARK, CT (MARK1, KIAA1477, MARK, Serine/threonine-protein kinase MARK1, MAP/microtubule affinity-regulating kinase 1, PAR1 homolog c) (PE)
-
Purification
-
Purified by Protein A affinity chromatography.
-
Immunogène
-
MARK antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the C-terminal region of human MARK.
-
Isotype
-
IgG
-
Top Product
-
Discover our top product MARK1 Anticorps primaire
-
-
-
Indications d'application
-
Optimal working conditions should be determined by the investigator.
-
Restrictions
-
For Research Use only
-
-
Format
-
Liquid
-
Buffer
-
Supplied as a liquid in PBS, pH 7.2.
-
Stock
-
4 °C
-
Stockage commentaire
-
4°C ,Do Not Freeze
-
-
Antigène
-
MARK1
(MAP/microtubule Affinity-Regulating Kinase 1 (MARK1))
-
Autre désignation
-
MARK (MARK1 Produits)
-
Synonymes
-
anticorps MGC80341, anticorps MARK1, anticorps AW491150, anticorps B930025N23Rik, anticorps Emk3, anticorps Par-1c, anticorps mKIAA1477, anticorps mPar-1c, anticorps MARK, anticorps Par1c, anticorps MAP/microtubule affinity-regulating kinase 1 S homeolog, anticorps microtubule affinity regulating kinase 1, anticorps MAP/microtubule affinity-regulating kinase 1, anticorps MAP/microtubule affinity regulating kinase 1, anticorps mark1.S, anticorps MARK1, anticorps mark1, anticorps Mark1
-
NCBI Accession
-
NP_061120
-
UniProt
-
Q9P0L2
-
Pathways
-
SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2
-